financetom
Business
financetom
/
Business
/
Shree Cements’ Q1FY21 today: Here’s what to expect
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Shree Cements’ Q1FY21 today: Here’s what to expect
Aug 10, 2020 1:42 AM

Shree Cements' will announce its Q1FY21 numbers on Monday amid the sector suffering from the demand slowdown due to the novel coronavirus induced lockdown.

Here's what the street is expecting from the cement major on the earnings front today:

Key Expectations

Volumes to drop 20% YoY vs 30%+ for the overall industry.

Volumes to decline due to favourable North/East market.

Volumes to drop die to no exposure to demand-hit South market.

Realisations expected to raise approx 2% (YoY).

EBITDA Margins Factors

Lower volumes will increase fixed costs.

Higher realisations.

Falling P&F costs led by a correction in petcoke prices.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Guidewire Software Insider Sold Shares Worth $830,448, According to a Recent SEC Filing
Guidewire Software Insider Sold Shares Worth $830,448, According to a Recent SEC Filing
Jun 20, 2024
05:33 PM EDT, 06/20/2024 (MT Newswires) -- John P Mullen, President & Chief Revenue Officer, on June 18, 2024, sold 6,176 shares in Guidewire Software ( GWRE ) for $830,448. Following the Form 4 filing with the SEC, Mullen has control over a total of 140,521 shares of the company, with 140,521 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1528396/000152839624000075/xslF345X03/wk-form4_1718918842.xml Price: 132.98,...
Beigene Insider Sold Shares Worth $368,162, According to a Recent SEC Filing
Beigene Insider Sold Shares Worth $368,162, According to a Recent SEC Filing
Jun 20, 2024
05:34 PM EDT, 06/20/2024 (MT Newswires) -- Lai Wang, Global Head of R&D, on June 17, 2024, sold 2,341 shares in Beigene ( BGNE ) for $368,162. Following the Form 4 filing with the SEC, Wang has control over a total of 1,796,717 shares of the company, with 1,738,529 shares held directly and 58,188 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1651308/000165130824000073/xslF345X03/wk-form4_1718918744.xml ...
Disc Medicine Insider Bought Shares Worth $3,000,024, According to a Recent SEC Filing
Disc Medicine Insider Bought Shares Worth $3,000,024, According to a Recent SEC Filing
Jun 20, 2024
05:32 PM EDT, 06/20/2024 (MT Newswires) -- Mona Ashiya, Director, on June 17, 2024, executed a purchase for 83,334 shares in Disc Medicine ( IRON ) for $3,000,024. Following the Form 4 filing with the SEC, Ashiya has control over a total of 235,391 shares of the company, with 235,391 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1816736/000094787124000574/xslF345X03/ownership.xml Price: 42.26, Change: +1.01, Percent...
Exxon-Hess arbitration panel incomplete, Hess sale to Chevron stalled
Exxon-Hess arbitration panel incomplete, Hess sale to Chevron stalled
Jun 20, 2024
HOUSTON, June 20 (Reuters) - A contract arbitration panel that could block or green-light the $53 billion sale of Hess Corp ( HES ) to Chevron ( CVX ) remains incomplete three months after the case was filed, stalling a decision on whether Exxon Mobil ( XOM ) has a right of first refusal over Hess' Guyana operations. The third...
Copyright 2023-2026 - www.financetom.com All Rights Reserved